Akoya Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
81.85 |
83.42 |
91.85 |
99.03 |
103.30 |
112.50 |
| Przychód Δ r/r |
0.00% |
1.92% |
10.11% |
7.82% |
4.31% |
8.91% |
| Przychód (min) |
80.68 |
82.34 |
78.04 |
97.12 |
95.75 |
104.27 |
| Przychód (max) |
82.50 |
85.21 |
105.32 |
100.95 |
111.84 |
121.80 |
| EBITDA (średnia) |
-42.42 |
-43.24 |
-47.61 |
-51.33 |
-53.54 |
-58.31 |
| EBIT (średnia) |
-49.93 |
-50.89 |
-56.03 |
-60.41 |
-63.01 |
-68.62 |
| EBIT % |
-61.00% |
-61.00% |
-61.00% |
-61.00% |
-61.00% |
-61.00% |
| Zysk netto (średni) |
-53.90 |
-39.96 |
-37.67 |
-29.98 |
-27.67 |
-25.20 |
| Zysk netto % |
-65.86% |
-47.90% |
-41.01% |
-30.27% |
-26.79% |
-22.40% |
| EPS (średnia) |
-1.10 |
-0.81 |
-0.68 |
-0.61 |
-0.56 |
-0.51 |
| Liczba analityków (Przychody) |
6 |
3 |
4 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
5 |
3 |
4 |
2 |
1 |
1 |
| symbol |
AKYA |
AKYA |
AKYA |
AKYA |
AKYA |
AKYA |